Nasdaq Study Shows Firms Turning to AI and Data Scientists to Enhance Regulatory Compliance
Notified -
Globe Newswire3-12-2024, 14:30
Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint 12-04-2023, 10:47